HHS/ASPR Biodefense + Bioterrorism Preparedness News

ASPR

The office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.

Biodefense Headlines – 31 March 2025

Biosecurity March 31, 2025

This week’s topics include restructuring of ASPR, anti-vaccine leadership at NIH, the UK’s new pathogen priority research targets list, and data on a post-exposure treatment for filoviruses. FEATURED Trump Administration…

ASPR

Call for Nominees: National Biodefense Science Board

HHS Awards $600M to 12 Manufacturers to Bolster COVID-19 Test Supply Chain

BugSeq Awarded BARDA DRIVe Funding to Develop Next-Gen Diagnostics for Any Respiratory RNA Virus

ORISE Research Fellowship for Advancing CBRN Medical Countermeasures

On Demand Pharmaceuticals Opens State-of-the-Art Manufacturing Facility in Maryland

U.S. Purchases 600,000 Courses of Eli Lilly Monoclonal Antibody That Works Against Omicron

Medical Countermeasures Surge Capacity Act of 2022 Introduced in Senate

US Government Invests in At-Home Single Swab Combined Flu, COVID Test

Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment

Why Moderna Won’t Share Rights to the COVID-19 Vaccine with the Government That Paid for Its Development

U.S. Plans to Expand Regional Ebola and Other Special Pathogen Treatment Centers

CBRNE Mass Casualty: Rapid Bedside Ultrasound Triage System Awarded BARDA Investment

Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines

Disaster Medicine: New Resource Prepares for Sepsis Encountered in Austere Conditions

BARDA Seeks Applications for Developing At-Home COVID-19 Diagnostics and Technologies

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Leidos Awarded DARPA Contract for Personalized Protective Biosystem Against Chemical and Biological Threats

Aidar Health’s Rapid Patient Triage System Gains Federal Funding From BARDA

BARDA-NCATS Partner with Vunjak-Novakovic Laboratory at Columbia University on Tissue-Chip Technology

Harvard’s Wyss Institute Receives Funding to Advance ‘Vaccination-on-a-chip’ Technology

Biodefense Headlines – 31 March 2025